How to Help Your Patients Find Veltassa in Stock: A Provider's Guide

For nephrologists, cardiologists, and internists who regularly prescribe Veltassa (patiromer), one of the most common sources of patient frustration is medication access. Patients call in saying their pharmacy doesn't carry it, their prior authorization was denied, or the co-pay is too high. This guide gives you and your care team a concrete toolkit for proactively helping patients find and obtain Veltassa.

Why Veltassa Is Hard for Patients to Access

Before solving the problem, it helps to understand it. Veltassa access issues stem from four key factors:

Specialty drug, not stocked everywhere. Most standard retail pharmacies don't carry Veltassa. Patients sent to their local CVS or Walgreens without guidance often find the drug isn't in stock.

Brand-only, high cost. With no generic available and retail pricing of $1,200–$1,500/month, patients without insurance or with high deductibles often cannot afford to fill the prescription even when it's available.

Prior authorization delays. Many plans require PA, and if the prescription arrives at a pharmacy before PA is approved, the patient may be left waiting days or weeks without medication.

Refrigeration requirement. Veltassa must be kept at 2–8°C, limiting which pharmacies can stock and ship it.

Strategy 1: Set Expectations at the Point of Prescribing

When you prescribe Veltassa, brief the patient immediately that finding it may require extra steps. Consider providing a printed or verbal handout that includes:

The name and phone number of one or two specialty pharmacies in your area known to carry Veltassa

Contact info for Veltassa Konnect (1-844-835-8277) for insurance and PA assistance

Information about the co-pay savings program (for commercially insured patients)

A reminder to take other oral medications at least 3 hours before or after Veltassa

Strategy 2: Build a Specialty Pharmacy Referral Relationship

The most effective way to reduce patient access friction is to identify one or two specialty pharmacies in your area that reliably stock Veltassa and are familiar with the PA requirements for your top insurance plans. Ask your office staff to maintain updated contact information for these pharmacies. When a patient is prescribed Veltassa, route the e-prescription directly to the specialty pharmacy rather than the patient's default retail pharmacy.

Some specialty pharmacies also offer home delivery, which solves the cold-chain problem for patients in rural areas or those with transportation barriers.

Strategy 3: Use Veltassa Konnect for PA and Benefits Support

Vifor Pharma's Veltassa Konnect program is a hub-and-spoke access support service. Key services include:

Benefits investigation: Verifying insurance coverage and copay tier before you send the prescription

Prior authorization support: Assistance initiating and following up on PA requests

Free 15-day starter supply: Patients can receive a free 15-day supply while coverage is being determined. A second 15-day supply is available if verification takes longer than expected.

Specialty pharmacy referral: Konnect can route the prescription to a specialty pharmacy in the patient's area

Having your office staff enroll patients in Veltassa Konnect at the point of prescribing is one of the single most impactful things you can do to prevent access gaps.

Strategy 4: Recommend medfinder for Pharmacy Searches

When a patient calls your office unable to find Veltassa, your care team can refer them to medfinder. The patient provides their medication, dosage, and ZIP code — medfinder calls local pharmacies to check which have the medication in stock, and texts the patient the results. This saves hours of frustration and speeds up access.

Strategy 5: Know When to Switch to Lokelma

If a patient has been unable to access Veltassa for more than a few days, and their potassium is rising, do not delay treatment while continuing to search for the medication. Lokelma (sodium zirconium cyclosilicate) is an appropriate alternative in most patients, with a simple prescription switch. Keep in mind: Lokelma is faster-acting, which may benefit acute hyperkalemia, but contains sodium — exercise caution in heart failure or edema-prone patients.

Documentation and Safety Considerations

Document any access barriers in the medical record, particularly if they lead to a therapeutic switch or a delay in therapy

Reinforce the importance of drug-timing counseling: all other oral meds must be separated by 3 hours from Veltassa

Remind patients not to abruptly discontinue Veltassa — potassium rebounds within 2 days. If a gap in therapy occurs, reassess electrolytes promptly

Schedule serum potassium and magnesium monitoring at regular intervals — especially after dose titrations or medication changes

Summary: Provider Action Checklist for Veltassa Access

Brief patients at prescribing on access challenges and co-pay programs

Route prescriptions to specialty pharmacies — not standard retail

Enroll patients in Veltassa Konnect for PA support and starter supply

Recommend medfinder for real-time local pharmacy searches

Switch to Lokelma if access delay puts patient at clinical risk

Monitor potassium and magnesium regularly